1. Kowalik, MM, Trzonkowski, P, Kowara, ML, Mital, A, Smiatacz, T, Jaguszewski, M. COVID-19 - toward a comprehensive understanding of the disease. Cardiol J. 2020;27(2):99-114.
Google Scholar | Crossref | Medline2. Van Doremalen, N, Morris, DH, Holbrook, MG, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564-1567.
Google Scholar | Crossref | Medline3. Mehra, MR, Desai, SS, Kuy, S, Henry, TD, Patel, AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382(25):e102.
Google Scholar | Crossref | Medline4. Zhou, F, Yu, T, Du, R, et al. Clinical course, and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.
Google Scholar | Crossref | Medline5. Hoffmann, M, Kleine-Weber, H, Schroeder, S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-280.
Google Scholar | Crossref | Medline6. Leg, S, Naviglio, S, Volpi, S, Tommasini, A. Recent insights into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19. Vaccines. 2020;8:224.
Google Scholar | Crossref7. Perrotta, F, Matera, MG, Cazzola, M, Bianco, A. Severe respiratory SARS-CoV-2 infection: does ACE2 receptor matter? Respir Med. 2020;168:105996.
Google Scholar | Crossref | Medline8. Dong, M, Zhang, M, Ma, X, et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020;131:110678.
Google Scholar | Crossref | Medline9. Qi, J, Zhou, Y, Hua, J, et al. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. Int J Environ Res Public Health. 2021;18(1):284.
Google Scholar | Crossref10. Li, Y, Zhang, Z, Yang, L, et al. The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience. 2020;23:101160.
Google Scholar | Crossref | Medline11. Lambeir, AM, Durinx, C, Scharpe, S, De Meester, I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci. 2003;40(3):209-294.
Google Scholar | Crossref | Medline | ISI12. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
Google Scholar | Crossref | Medline13. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.
Google Scholar | Crossref | Medline14. Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
Google Scholar | Crossref | Medline15. Inciardi, RM, Adamo, M, Lupi, L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41:1821-1829.
Google Scholar | Crossref | Medline16. Yang, X, Yu, Y, Xu, J, et al. Clinical course, and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-481.
Google Scholar | Crossref | Medline17. Wu, C, Chen, X, Cai, Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943.
Google Scholar | Crossref | Medline18. Guan, W, Ni, Z, Hu, Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
Google Scholar | Crossref | Medline19. Liu, L, Fang, Y, Deng, Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J. 2020;133(9):1025-1031.
Google Scholar | Crossref | Medline20. Liu, PP, Blet, A, Smyth, D, Li, H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68-78.
Google Scholar | Crossref | Medline21. Yan, Y, Yang, Y, Wang, F, et al. Clinical characteristics, and outcomes of patients with severe COVID-19 with diabetes. BMJ Open Diabetes Res Care. 2020;8(1):e001343.
Google Scholar | Crossref | Medline22. Yang, J, Zheng, Y, Gou, X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-95.
Google Scholar | Crossref | Medline23. Cao, Y, Liu, X, Xiong, L, Cai, K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol. 2020;92(9):1449-1459.
Google Scholar | Crossref | Medline24. Simmonet, A, Chetboun, M, Poissy, J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020;28(7):1195-1199.
Google Scholar | Crossref | Medline25. Zhu, L, She, ZG, Cheng, X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068-1077.
Google Scholar | Crossref | Medline26. Zheng, Z, Peng, F, Xu, B, et al. Risk factors of critical and mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-e25.
Google Scholar | Crossref | Medline27. Shi, Q, Zhang, X, Jiang, F, et al. Clinical characteristics, and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care. 2020;43(7):1382-1391.
Google Scholar | Crossref | Medline28. Pranata, R, Huang, J, Lim, MA, Wahjoepramono, EJ, July, J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020;29(8):104949.
Google Scholar | Crossref29. Aggarwal, G, Cherniyot, I, Aggarwal, S, et al. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: a meta-analysis. Curr Probl Cardiol. 2020;45(8):100617.
Google Scholar | Crossref | Medline30. Ruan, Q, Yang, K, Wang, W, Jiang, L, Song, J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-848.
Google Scholar | Crossref | Medline31. Li, B, Yang, J, Zhao, F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531-538.
Google Scholar | Crossref | Medline32. Cheng, P, Zhu, H, Witteles, RM, et al. Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty. Curr Cardiol Rep. 2020;22:34.
Google Scholar | Crossref | Medline33. Guzik, TJ, Mohiddin, SA, Dimarco, A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-1687.
Google Scholar | Crossref | Medline34. Michalakis, K, Ilias, I. SARS-CoV-2 infection and obesity: common inflammatory and metabolic aspects. Diabetes Metab Syndr. 2020;14:469-471.
Google Scholar | Crossref | Medline35. Zhang, AJ, To, KK, Li, C, et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A (H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J Infect Dis. 2020;207:1270-1280.
Google Scholar | Crossref36. Frydrych, LM, Bian, G, O’Lone, DE, Ward, PA, Delano, MJ. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525-534.
Google Scholar | Crossref | Medline37. Byrne, CJ, Khurana, S, Kumar, A, Tai, TC. Inflammatory signaling in hypertension: regulation of adrenal catecholamine biosynthesis. Front Endocrinol. 2018;28(9):343.
Google Scholar | Crossref38. Unudurthi, SD, Luthra, P, Bose, RJC, McCarthy, JR, Kontaridis, MI. Cardiac inflammation in COVID-19: lessons from heart failure. J Life Sci. 2020;260:118482.
Google Scholar | Crossref39. Galbadage, T, Peterson, BM, Awada, J, et al. Systematic review and meta-analysis of sex specific COVID-19 clinical outcomes. Front Med (Lausanne). 2020;23(7):348.
Google Scholar | Crossref40. Del Sole, F, Farcomeni, A, Loffredi, L, et al. Features of severe COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13378.
Google Scholar | Crossref | Medline41. Figliozzi, S, Masci, PG, Ahmadi, N, et al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50:e13362.
Google Scholar | Crossref | Medline42. Ortolan, A, Lorenzin, M, Felicetti, M, Doria, A, Ramonda, R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis. 2020;99:496-504.
Google Scholar | Crossref | Medline43. Rossi, PG, Marino, M, Formisano, D, et al. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the province of Reggio Emilia, Italy. PLoS One. 2020;15(8):e0238281.
Google Scholar | Medline44. Nasiri, MJ, Haddadi, S, Tahvildari, A, et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: systematic review and meta-analysis. Front Med (Lausanne). 2020;7:459.
Google Scholar | Crossref | Medline45. Meng, Y, Wu, P, Lu, W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520.
Google Scholar | Crossref | Medline46. Mertz, D, Kim, TH, Johnstone, J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.
Google Scholar | Crossref | Medline47. Oudit, GY, Kassiri, Z, Jiang, C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-625.
Google Scholar | Crossref | Medline48. Guo, J, Wei, X, Li, Q, et al. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol. 2020;235(12):9884-9894.
Google Scholar | Crossref | Medline49. Bansal, M. Cardiovascular disease and COVID-19. Diabet Metabol Syndr. 2020;14:247-250.
Google Scholar | Crossref | Medline50. Gupta, AK, Jneid, H, Addison, D, et al. Current perspectives on coronavirus 2019 (COVID-19) and cardiovascular disease: a white paper by the JAHA editors. J Am Heart Assoc. 2020;2019(4):e017013.
Google Scholar51. Klok, FA, Kruip, MJHA, van der Meer, NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147.